The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AGY ALLERGY THERAPEUTICS PLC ORD 0.1P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 13-Jul-2016 AGY Trading Update RNS +3.84% Up
07:00 08-Jul-2016 AGY Results of mite immunotherapy Acarovac PlusT RNS +1.59% Up
07:00 27-Jun-2016 AGY Findings from mEEC dose range finding study G204 RNS -22.45% Down
07:00 13-Jun-2016 AGY Allergy hosts Satellite Symposium at EAACI RNS -
07:00 10-Jun-2016 AGY Appointment of Finance Director RNS -
07:00 09-May-2016 AGY Positive Phase II Data RNS -
09:02 23-Mar-2016 AGY Issue of equity in respect of options exercise RNS -1.07% Down
07:00 17-Mar-2016 AGY Board Change RNS -1.67% Down
16:36 11-Mar-2016 AGY Grant of Options under Long Term Incentive Plan RNS -2.10% Down
07:00 08-Mar-2016 AGY Interim Results for the six months ended 31/12/15 RNS -0.73% Down
07:30 24-Feb-2016 AGY Hardman & Co Research Report: Development Progress RNS +3.47% Up
07:00 23-Feb-2016 AGY Notice of Interim Results RNS +2.51% Up
07:00 18-Feb-2016 AGY Patient enrolment completed in US Phase IIb study RNS +0.19% Up
07:00 13-Jan-2016 AGY Trading Update RNS -9.10% Down
07:00 07-Dec-2015 AGY US Phase II study for GrassMATAMPL initiated RNS +1.96% Up
15:47 02-Dec-2015 AGY Holding(s) in Company RNS +1.90% Up
07:00 30-Nov-2015 AGY PQBirch204 Phase II study update RNS +2.41% Up
15:21 27-Nov-2015 AGY Holding(s) in Company RNS +2.67% Up
18:06 25-Nov-2015 AGY Grant of Options under Long Term Incentive Plan RNS +2.52% Up
12:23 18-Nov-2015 AGY Result of AGM RNS -1.60% Down

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address Dominion Way, Worthing, BN14 8SA, United Kingdom
Company website http://www.allergythera...
Market cap(in millions)* £ 114.44
Listing/Admission to trading 11 Oct 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
25-Jul-16
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 10,000
SEDOL B02LCQ0
ISIN number GB00B02LCQ05



ALLERGY THERA. share news analysis (AGY)